HIV & AIDS

Pillar of HIV prevention (PrEP)—how to implement

A pillar of the federal government's plans to fight the HIV epidemic is PrEP: pre-exposure prophylaxis. For someone who is HIV-negative but at risk of becoming infected, this means taking anti-retroviral drugs before possible ...

HIV & AIDS

FDA review favors first drug for HIV prevention (Update)

(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.

HIV & AIDS

Five key numbers on AIDS

Ahead of World AIDS Day on Friday, here is a snapshot in numbers, based on UN data, of the deadly disease which was identified in the early 1980s.

HIV & AIDS

Viruses skip species by changing rapidly

While it may be that some Americans doubt we're related to chimps and other primates, viruses recognize the similarities in our cells.

HIV & AIDS

HIV epidemic: Successful use of self-tests in rural Africa

Despite significant progress in prevention and therapy, millions of people still get infected with HIV every year. The main burden of HIV/AIDS falls on Africa. To contain the epidemic, innovative methods are needed to enable ...

Medications

The opioid crisis: What we should learn from the AIDS epidemic

There are important lessons to be learned from the successes and failures of the AIDS response that could inform our response to the opioid epidemic, according to a new paper by researchers at the Columbia University Mailman ...

HIV & AIDS

Ten million more people advised to take HIV drugs: UN

Nearly 10 million more people infected with the AIDS virus now meet medical standards for receiving HIV drugs, according to revised UN guidelines released on Sunday, which experts say could avert 6.5 million deaths or new ...

HIV & AIDS

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

page 4 from 10